Form D · Manufacturing
Perfinity Biosciences, Inc.
West Lafayette, IN · CIK 0001488641
Offering snapshot reported Jun 29, 2010 · SEC filing
- Reported sold
- $2.33M Offering amount: $2.5M
- Investors reported
- 22 Form D · investor count
- Minimum accepted
- $1K Reported outside-investor minimum
- First sale
- Jun 14, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 29, 2010 | Initial | $2,329,089 | No comparison | 22 | SEC filing |
| May 20, 2010 | Initial | $2,327,769 | No comparison | 156 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-144164
Source: Form D, filed Jun 29, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Frank Cheng | Director |
| Michael A. Evans | Director |
| Timothy R. Franson | Director |
| Stephen P. Hokanson | Director, Executive |
| R. Matthew Neff | Director |
| Drew F. Peyronnin | Director |
| Steven Plump | Executive |
| Fred Regnier | Director |
Issuer details
Industry: Manufacturing (See others in industry)
Address:
3000 Kent Avenue
West Lafayette, IN, 47906
West Lafayette, IN, 47906